Wuhan EasyDiagnosis Biomedicine Co., Ltd was established in Wuhan Optics Valley in 2008 and went public in 2018 (Shenzhen Stock Exchange code 002932), EasyDiagnosis is a Chinese national high-tech enterprise specializing in R&D, production and sales of In-Vitro Diagnostics reagents and auxiliary equipment in fields of POCT, chemiluminescence, blood gas analysis, molecular diagnosis, etc.
We were the first company in China to make bedside, rapid quantitative detection in whole blood, and now we have a strong and professional R&D team, with class 100,000 cleanroom workshop and international leading production lines. Our POCT products cover fields of cardiovascular disease, kidney disease, infectious disease, endocrine and metabolic diseases, obstetrics, gynecology disease and physical examination. EasyDiagnosis have been certified with ISO13485：2016, so far we have more than 100 products certified with NMPA and 8 products with CE certification, we have 68 authorized patents, in the meantime, our sales network has reached about 100 countries and regions across the world.
Our vision is to become a top enterprise providing innovative and leading medical products and services for medical institutions, EasyDiagnosis is looking forward to working with you and creates a beautiful future for human health.